Of all the multimer-reactive CD8+ T cell populations, 46 were T-Ag–specific, and hence tumor relevant, with 1–8 populations detected in 14 patients with MCPyV-positive tumors at summed estimated frequencies among CD8+ T cells ranging from 0.1% to 1% (Figure 2A). Here, CD8A is linked to neoplasm.